Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis

One of the target drugs for plaque psoriasis treatment is apremilast, which is a selective phosphodiesterase 4 (PDE4) inhibitor. In this study, 34 moderate-to-severe and severe plaque psoriasis patients from Russia were treated with apremilast for 26 weeks. This allowed us to observe the effectivene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pers Med
Main Authors: Verbenko, Dmitry A., Karamova, Arfenya E., Artamonova, Olga G., Deryabin, Dmitry G., Rakitko, Alexander, Chernitsov, Alexandr, Krasnenko, Anna, Elmuratov, Artem, Solomka, Victoria S., Kubanov, Alexey A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7823747/
https://ncbi.nlm.nih.gov/pubmed/33383665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11010020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados